Skip to main content
. 2022 Sep 30;50:50–56. doi: 10.1016/j.athplu.2022.09.002

Fig. 2.

Fig. 2

Cumulative freedom from the risk of MACE during 3 years of follow-up.

Patients classified into the first and the second tertiles of the fc-/m-PCSK9 ratio at 48 h showed significantly favorable outcomes compared with those classified in to the third tertile in terms of all-cause death, nonfatal myocardial infarction and stroke, or new AP (log-rank test χ2: 7.8362, p<0.01).